Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06791083 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Study of Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant Treatment of Gastric Cancer

Name: Clinical Study of Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant Treatment of Gastric Cancer — clinical trial record (NCT06791083)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 2

SponsorFirst Affiliated Hospital of Fujian Medical University

Started2024-06-20

View on ClinicalTrials.gov ↗

Record status

This record was last updated January 24, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.

First Affiliated Hospital of Fujian Medical University

56 trials monitored

See all monitored trials

Gastric Cancer

1,194 trials monitored

See 60 trials at risk

To observe and evaluate the neoadjuvant treatment of Envafolimab combined with Fruquintinib and chemotherapy for locally advanced gastric/gastroesophageal junction carcinoma

Trial Details

NCT Number	NCT06791083
Lead Sponsor	First Affiliated Hospital of Fujian Medical University
Conditions	Gastric Cancer
Enrollment	40 participants
Start Date	2024-06-20
Primary Completion	2025-12 (estimated)
Study Completion	2027-05 (estimated)
Updated on ClinicalTrials.gov	2025-01-24